The role of hypoxia in pancreatic cancer: a potential therapeutic target?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of hypoxia in pancreatic cancer: a potential therapeutic target?
Authors
Keywords
-
Journal
Expert Review of Gastroenterology & Hepatology
Volume 10, Issue 3, Pages 301-316
Publisher
Informa UK Limited
Online
2015-11-11
DOI
10.1586/17474124.2016.1117386
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Results from a phase I, dose-escalation study of PX-478, an orally available inhibitor of HIF-1α.
- (2017) R. Tibes et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimidazole tracer pimonidazole
- (2015) N C Dhani et al. BRITISH JOURNAL OF CANCER
- Distribution of Gemcitabine Is Nearly Homogenous in Two Orthotopic Murine Models of Pancreatic Cancer
- (2015) Robin M. Kramer et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer
- (2015) S. Kordes et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma
- (2015) Martin C. Whittle et al. CELL
- Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing Analysis
- (2015) M. Dal Molin et al. CLINICAL CANCER RESEARCH
- Loss of SOD3 (EcSOD) Expression Promotes an Aggressive Phenotype in Human Pancreatic Ductal Adenocarcinoma
- (2015) B. R. O'Leary et al. CLINICAL CANCER RESEARCH
- Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy
- (2015) Bryan W Miller et al. EMBO Molecular Medicine
- A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling
- (2015) Bo Kong et al. GUT
- Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer
- (2015) Mitesh J. Borad et al. JOURNAL OF CLINICAL ONCOLOGY
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
- (2015) Richard A Moffitt et al. NATURE GENETICS
- Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma
- (2015) Tiansuo Zhao et al. Oncotarget
- High Expression of HIF1a Is a Predictor of Clinical Outcome in Patients with Pancreatic Ductal Adenocarcinomas and Correlated to PDGFA, VEGF, and bFGF
- (2015) Andreas-Claudius Hoffmann et al. NEOPLASIA
- Cancer-Stellate Cell Interactions Perpetuate the Hypoxia-Fibrosis Cycle in Pancreatic Ductal Adenocarcinoma
- (2015) Mert Erkan et al. NEOPLASIA
- Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
- (2014) S R McKeown BRITISH JOURNAL OF RADIOLOGY
- Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
- (2014) Berna C. Özdemir et al. CANCER CELL
- Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
- (2014) Andrew D. Rhim et al. CANCER CELL
- Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
- (2014) J. Chapiro et al. CLINICAL CANCER RESEARCH
- Gemcitabine Resistance is Associated with Epithelial-Mesenchymal Transition and Induction of HIF-1α in Pancreatic Cancer Cells
- (2014) Rui Wang et al. CURRENT CANCER DRUG TARGETS
- Extracellular superoxide dismutase suppresses hypoxia-inducible factor-1α in pancreatic cancer
- (2014) Zita A. Sibenaller et al. FREE RADICAL BIOLOGY AND MEDICINE
- The wonders of 2-deoxy-d-glucose
- (2014) Haibin Xi et al. IUBMB LIFE
- Hypoxia-inducible factor 1α expression and its clinical significance in pancreatic cancer: A meta-analysis
- (2014) Long-Yun Ye et al. PANCREATOLOGY
- Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells
- (2013) Haitao Zhu et al. Cancer Cell International
- Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors
- (2013) Woondong Jeong et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- PanIN-Specific Regulation of Wnt Signaling by HIF2 during Early Pancreatic Tumorigenesis
- (2013) A. Criscimanna et al. CANCER RESEARCH
- Hypoxia Triggers Hedgehog-Mediated Tumor-Stromal Interactions in Pancreatic Cancer
- (2013) T. R. Spivak-Kroizman et al. CANCER RESEARCH
- HIF1 Contributes to Hypoxia-Induced Pancreatic Cancer Cells Invasion via Promoting QSOX1 Expression
- (2013) Chen-Ye Shi et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation
- (2013) Li Liu et al. INTERNATIONAL JOURNAL OF CANCER
- An Undesired Effect of Chemotherapy
- (2013) Sumit Arora et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
- (2013) Gregg L. Semenza JOURNAL OF CLINICAL INVESTIGATION
- Hedgehog signaling regulates hypoxia induced epithelial to mesenchymal transition and invasion in pancreatic cancer cells via a ligand-independent manner
- (2013) Jianjun Lei et al. Molecular Cancer
- Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
- (2013) Jaekyoung Son et al. NATURE
- Unraveling the therapeutic potential of the Hedgehog pathway in cancer
- (2013) Dereck Amakye et al. NATURE MEDICINE
- The role of pancreatic stellate cells in pancreatic cancer
- (2013) Mert Erkan PANCREATOLOGY
- Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma
- (2013) F. Guillaumond et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells
- (2013) Sarah-Maria Fendt et al. Nature Communications
- Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels
- (2013) Bo Kong et al. Frontiers in Physiology
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
- (2012) Paolo P. Provenzano et al. CANCER CELL
- A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
- (2012) Luis E. Raez et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
- (2012) Haoqiang Ying et al. CELL
- Attenuation of reactive oxygen species by antioxidants suppresses hypoxia-induced epithelial-mesenchymal transition and metastasis of pancreatic cancer cells
- (2012) Yoshihide Shimojo et al. CLINICAL & EXPERIMENTAL METASTASIS
- Tumour budding is a strong and independent prognostic factor in pancreatic cancer
- (2012) E. Karamitopoulou et al. EUROPEAN JOURNAL OF CANCER
- Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
- (2012) Michael A Jacobetz et al. GUT
- MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors
- (2012) Kivanç Birsoy et al. NATURE GENETICS
- Hypoxia Induces EMT in Low and Highly Aggressive Pancreatic Tumor Cells but Only Cells with Cancer Stem Cell Characteristics Acquire Pronounced Migratory Potential
- (2012) Alexei V. Salnikov et al. PLoS One
- Hypoxia-Inducible Factor-1α Regulates Chemotactic Migration of Pancreatic Ductal Adenocarcinoma Cells through Directly Transactivating the CX3CR1 Gene
- (2012) Tiansuo Zhao et al. PLoS One
- MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer
- (2012) N. V. Chaika et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pigment Epithelium-Derived Factor Associates With Neuropathy and Fibrosis in Pancreatic Cancer
- (2011) Tamar Samkharadze et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Polymorphisms in the hypoxia-inducible factor-1α gene confer susceptibility to pancreatic cancer
- (2011) Xiuchao Wang et al. CANCER BIOLOGY & THERAPY
- Hypoxia Predicts Aggressive Growth and Spontaneous Metastasis Formation from Orthotopically Grown Primary Xenografts of Human Pancreatic Cancer
- (2011) Q. Chang et al. CANCER RESEARCH
- Hypoxia activates the hedgehog signaling pathway in a ligand-independent manner by upregulation of Smo transcription in pancreatic cancer
- (2011) Hideya Onishi et al. CANCER SCIENCE
- Transcriptional upregulation of MT2-MMP in response to hypoxia is promoted by HIF-1α in cancer cells
- (2011) Shikai Zhu et al. MOLECULAR CARCINOGENESIS
- Antiangiogenic therapy, hypoxia and metastasis: risky liaisons, or not?
- (2011) Katrien De Bock et al. Nature Reviews Clinical Oncology
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypoxia Induces Tumor Aggressiveness and the Expansion of CD133-Positive Cells in a Hypoxia-Inducible Factor-1α-Dependent Manner in Pancreatic Cancer Cells
- (2011) Okito Hashimoto et al. PATHOBIOLOGY
- Nuclear Factor-κB–Dependent Epithelial to Mesenchymal Transition Induced by HIF-1α Activation in Pancreatic Cancer Cells under Hypoxic Conditions
- (2011) Zhuo-Xin Cheng et al. PLoS One
- Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of -ketoglutarate to citrate to support cell growth and viability
- (2011) D. R. Wise et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor Budding as a Strong Prognostic Indicator in Invasive Ampullary Adenocarcinomas
- (2010) Nobuyuki Ohike et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies
- (2010) Milind M Javle et al. BMC CANCER
- Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation
- (2010) N Hiraoka et al. BRITISH JOURNAL OF CANCER
- Loss of FOXA1/2 Is Essential for the Epithelial-to-Mesenchymal Transition in Pancreatic Cancer
- (2010) Y. Song et al. CANCER RESEARCH
- Stromal biology and therapy in pancreatic cancer
- (2010) A. Neesse et al. GUT
- Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
- (2010) Hedy Lee Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanisms of Motility in Metastasizing Cells
- (2010) Mahmut Yilmaz et al. MOLECULAR CANCER RESEARCH
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- BCL-xL Is a Target Gene Regulated by Hypoxia-inducible Factor-1α
- (2009) Ni Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer
- (2008) Atsushi Masamune et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Tube Travel: The Role of Proteases in Individual and Collective Cancer Cell Invasion
- (2008) P. Friedl et al. CANCER RESEARCH
- Pancreatic Stellate Cells: Partners in Crime with Pancreatic Cancer Cells
- (2008) A. Vonlaufen et al. CANCER RESEARCH
- Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression
- (2008) R. F. Hwang et al. CANCER RESEARCH
- The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma
- (2008) Mert Erkan et al. Clinical Gastroenterology and Hepatology
- Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia
- (2008) Huafeng Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oral mTOR Inhibitor Everolimus in Patients With Gemcitabine-Refractory Metastatic Pancreatic Cancer
- (2008) Brian M. Wolpin et al. JOURNAL OF CLINICAL ONCOLOGY
- Potent and Highly Selective Hypoxia-Activated Achiral Phosphoramidate Mustards as Anticancer Drugs
- (2008) Jian-Xin Duan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
- (2008) William G. Kaelin et al. MOLECULAR CELL
- Turning anti-ageing genes against cancer
- (2008) Valter D. Longo et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Digoxin and other cardiac glycosides inhibit HIF-1 synthesis and block tumor growth
- (2008) H. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation